KANG [iKang Healthcare] 6-K: (Original Filing)

[iKang Announces Update on Going Private Transaction As previously disclosed, under the Merger Agreement, either the Company or Parent have the right to terminate the Merger Agreement if the Merger has not been completed by October 31, 2018 (the “Termination Date”). Accordingly, as the Termination Da]

KANG [iKang Healthcare] 6-K: iKang Announces Update on Going Private Transaction As

[iKang Announces Update on Going Private Transaction As previously disclosed, under the Merger Agreement, either the Company or Parent have the right to terminate the Merger Agreement if the Merger has not been completed by October 31, 2018 (the “Termination Date”). Accordingly, as the Termination Da]

KANG [iKang Healthcare] 6-K: iKang Announces Update on Going Private Transaction As

[iKang Announces Update on Going Private Transaction As previously disclosed, under the Merger Agreement, either the Company or Parent have the right to terminate the Merger Agreement if the Merger has not been completed by October 31, 2018 (the “Termination Date”). Accordingly, as the Termination Da]

KANG [iKang Healthcare] 6-K: (Original Filing)

[iKang Announces Update on Going Private Transaction As previously disclosed, under the Merger Agreement, either the Company or Parent have the right to terminate the Merger Agreement if the Merger has not been completed by October 31, 2018 (the “Termination Date”). Accordingly, as the Termination Da]

KANG [iKang Healthcare] SC 13G/A: (Original Filing)

[*The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information requir]

KANG [iKang Healthcare] SC 13G/A: *The remainder of this cover page shall be

[*The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information requir]

KANG [iKang Healthcare] 6-K: (Original Filing)

[iKang Announces Unaudited Financial Results for the Fiscal First Quarter Ended June 30, 2018 BEIJING, SEPTEMBER 27, 2018 (GLOBE NEWSWIRE) — iKang Healthcare Group, Inc. (“iKang” or the “Company”) (Nasdaq: KANG), a major provider in China’s fast growing private preventive healthcare services market, ]

KANG [iKang Healthcare] 6-K: iKang Announces Unaudited Financial Results for the Fiscal

[iKang Announces Unaudited Financial Results for the Fiscal First Quarter Ended June 30, 2018 BEIJING, SEPTEMBER 27, 2018 (GLOBE NEWSWIRE) — iKang Healthcare Group, Inc. (“iKang” or the “Company”) (Nasdaq: KANG), a major provider in China’s fast growing private preventive healthcare services market, ]

KANG [iKang Healthcare] SC 13D/A: (Original Filing)

[SCHEDULE 13D iKang Healthcare Group, Inc. (Name of Issuer) Class A Common Shares, par value US$0.01 per share** American Depositary Shares, each representing 1/2 Class A Common Share (Title of Class of Securities) 45174L108*** (CUSIP Number) Mr. Boquan He Unit 3213, Metro Plaza No. 183-187 Tianhe Ro]

KANG [iKang Healthcare] SC 13D/A: SCHEDULE 13D iKang Healthcare Group, Inc. (Name of

[SCHEDULE 13D iKang Healthcare Group, Inc. (Name of Issuer) Class A Common Shares, par value US$0.01 per share** American Depositary Shares, each representing 1/2 Class A Common Share (Title of Class of Securities) 45174L108*** (CUSIP Number) Mr. Boquan He Unit 3213, Metro Plaza No. 183-187 Tianhe Ro]

Skip to toolbar